Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.



Jeffrey Albers

CEO, President and Member of the Board of Directors

Anthony Boral M.D-Ph.D.

Chief Medical Officer

Marion. Dorsch Ph.D

Chief Scientific Officer

Debbie Durso-Bumpus

Senior Vice President, Human Resources

Kate Haviland

Chief Business Officer

Mike Landsittel

Vice President, Finance

Christoph Lengauer Ph.D.

Executive Vice President

Tracey L. McCain Esq.

Chief Legal Officer, Executive Vice President and Chief Compliance Officer

Christopher Murray Ph.D.

Senior Vice President, Technical Operations

Christina Rossi

Chief Commercial Officer